TABLE 6.
Risk factor | Univariate analysis | Multivariate analysis | ||||
---|---|---|---|---|---|---|
P value | OR | 95% CI | P value | OR | 95% CI | |
Heart failure | .078 | 1.39 | 0.96‐1.99 | |||
Chronic kidney disease | <.001 | 1.84 | 1.29‐2.60 | |||
Acute renal dysfunction | <.001 | 1.92 | 1.54‐2.40 | <.001 | 2.40 | 1.70‐3.40 |
Acute hepatic dysfunction | .002 | 1.53 | 1.17‐2.00 | |||
Hydroxychloroquine | <.001 | 1.85 | 1.47‐2.34 | .086 | 1.50 | 0.94‐2.40 |
Lopinavir‐ritonavir | <.001 | 0.62 | 0.48‐0.79 | |||
Azithromycin coadministration | <.001 | 2.02 | 1.60‐2.55 | |||
Oseltamivir | .041 | 0.55 | 0.30‐0.98 | |||
Remdesivir | .059 | 0.45 | 0.19‐1.05 | |||
Furosemide | <.001 | 2.00 | 1.50‐2.66 | |||
Betablocker | <.001 | 1.60 | 1.27‐2.02 | .023 | 1.50 | 1.05‐2.10 |
Abbreviations: CI, confidence interval; OR, odds ratio.